Trial intelligence / Profile preview

Saline vs Heparin Flush for Peripheral Venous Catheters in Children

NCT01794767Phase 4Suspended

Sponsor
Università degli Studi di Firenze
Start
Jan 2013
Primary completion
Aug 2014
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of heparin in catheter obstruction and phlebitis (2 arms), sponsored by Università degli Studi di Firenze. Primary endpoint: Average length of stay on site of the catheter at 10 days. Started Jan 2013; status: suspended.

02

Drugs

heparin
03

Conditions

catheter obstructionphlebitis

Beyond the preview

Go deeper on NCT01794767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01794767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call